Selank is a synthetic heptapeptide developed from tuftsin, a naturally occurring tetrapeptide fragment of immunoglobulin G. Researchers at the Russian Academy of Sciences engineered the compound by extending the tuftsin sequence (Thr-Lys-Pro-Arg) with an additional tripeptide tail to enhance metabolic stability. The result is a seven-amino-acid chain — Thr-Lys-Pro-Arg-Pro-Gly-Pro — that retains structural similarities to endogenous peptides while offering greater resistance to enzymatic degradation. This combination of biological relevance and improved stability has made Selank a recurring subject in neuropharmacology and immunology research.
Molecular Structure and Key Properties
Selank carries the molecular formula C33H57N11O9 and a molecular weight of approximately 751.87 g/mol. Its seven-residue sequence contains proline at multiple positions, a structural feature that limits rotational flexibility in the peptide backbone and contributes directly to the compound’s resistance to proteolytic cleavage — the enzymatic breakdown that quickly degrades many shorter peptides. This rigidity also influences how the molecule interacts with receptor sites and binding proteins in experimental systems. In laboratory settings, Selank is typically handled as a lyophilized white powder and reconstituted in aqueous buffer or sterile saline, depending on the assay requirements. The compound demonstrates reasonable solubility in water and exhibits stability under refrigerated storage conditions, though researchers generally avoid repeated freeze-thaw cycles to preserve integrity.
Research Applications
Much of the published preclinical work on Selank centers on its interactions with the GABAergic and serotonergic systems. In rodent models, researchers have measured changes in GABA receptor subunit expression and benzodiazepine receptor binding following administration, making it a tool for studying anxiety-related neurochemistry without directly using classical benzodiazepine ligands. Separately, studies have examined how Selank modulates brain-derived neurotrophic factor (BDNF) expression — a signaling protein involved in neuronal survival and synaptic plasticity — in cortical and hippocampal tissue preparations. In vitro work has also explored the peptide’s interactions with enkephalin-degrading enzymes, where Selank appears to inhibit specific metallopeptidases, extending the half-life of endogenous opioid peptides in cell culture environments. On the immunological side, researchers have used Selank to probe tuftsin-related pathways, measuring cytokine expression profiles — particularly interleukin-6 and tumor necrosis factor-alpha — in immune cell lines. These parallel lines of investigation reflect the compound’s structural origins and its utility as a research probe across multiple biological systems.
Analytical Use and Sourcing Considerations
Researchers working with Selank typically require purity at or above 98%, verified by high-performance liquid chromatography (HPLC). Mass spectrometry confirmation of the correct molecular weight is standard practice before the compound enters any assay workflow, as sequence errors or truncated fragments can confound results without producing obvious visual differences in the material. Certificate of Analysis documentation should include both HPLC trace data and mass spec results at minimum. Because Selank contains multiple amide bonds susceptible to hydrolysis under prolonged exposure to moisture, lyophilized stock should be stored at -20°C in sealed, desiccated conditions. Working aliquots in solution are generally prepared fresh or stored short-term at 4°C. When evaluating suppliers, procurement staff should request lot-specific documentation rather than generic certificates, and confirm that synthesis was performed under controlled GMP-aligned conditions to ensure reproducibility across experimental batches.
Selank’s dual structural lineage — part endogenous immunopeptide, part engineered stability scaffold — positions it as a versatile research tool at the intersection of neuropharmacology and immunology, and ongoing preclinical investigation continues to map the receptor interactions and signaling consequences that make it a compound of sustained scientific interest.
For Research Use Only. Not for human consumption. All compounds described in this article are supplied as analytical-grade reagents for institutional in vitro laboratory research only. Not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
